Opko Health (OPK) Stock: Buy, Sell, or Hold?
OPK - Opko Health Inc.
$1.57
0.08 (5.37%)
▲
5d:
-2.48%
30d:
+12.95%
90d:
+8.28%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 04, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 8, 2026 at $1.55 · last confirmed Sep 10, 2026
Strength: 6.0/10
Get Alerted When OPK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: OPK shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: OPK shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: OPK is currently trading at $1.57, which is considered extended relative to its 30-day fair value range of $1.36 to $1.56.
Technical Outlook: Technically, OPK is in a uptrend. Immediate support is located at $1.46, while resistance sits at $1.73. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: OPK scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.38 (+178.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OPK is in a uptrend. Immediate support is located at $1.46, while resistance sits at $1.73. The stock is showing strong short-term momentum, up 5.4% recently.
Market Sentiment: OPK scores 37/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.38 (+178.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.36 -
$1.56
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
31.6%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (37/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+5.4%)
- BULLISH: Trading 178.7% below Wall St target ($4.38)
- WARNING: Composite score 43/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.36 -
$1.56
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.46
Resistance Level
$1.73
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-5.71
Wall Street Target
$4.38
(+178.7%)
Revenue Growth (YoY)
4.3%
Earnings Growth (YoY)
-12.6%
Profit Margin
-12.4%
Share & Embed Analysis
Last updated: September 13, 2026 10:41 AM ET
Data refreshes hourly during market hours. Next update: 11:41 AM
Data refreshes hourly during market hours. Next update: 11:41 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPK showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
John A Paganelli
BUY
10000 shares
2026-03-20
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$645 | 51 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 52 HOLD |
|
DHR
Danaher Corporation |
STRONG BUY
25 analysts |
$229 | 49 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
23 analysts |
$196 | 49 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$344 | 47 HOLD |
